References
Albin, R. L., Young, A. B., & Penney, J. B. (1989). The functional
anatomy of basal ganglia disorders. Trends in neurosciences ,12 (10), 366-375.
Alexander, S. P., Battey, J., Benson, H. E., Benya, R.V., Bonner, T.I.,
Davenport, A.P., Dhanachandra. K. S., Eguchi, S., Harmar, A., Holliday,
N., Jensen, R. T., Karnik, S., Kostenis, E., Liew, W. C., Monaghan, A.
E., Mpamhanga, C., Neubig, R., Pawson, A.J., Pin, J. P., Sharman, J. L.,
Spedding, M., Spindel, E., Stoddart, L., Storjohann, L., Thomas, W. G.,
Tripula, K., & Vanderheyden, P. (2023). Class A Orphans in GtoPdb
v.2023.1. IUPHAR/PBS Guide to Pharmacology.
https://doi.org/10.2218/gtopdb/F16/2023.1 .
Alexander, S. P., Christopoulos, A., Davenport, A. P., Kelly, E.,
Marrion, N. V., Peters, J. A., Faccenda, E., Harding, S. D., Pawson, A.
J., Sharman, J. L., Southan, C., Davies, J. A., & Collaborators, C.
(2017). THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled
receptors. Br J Pharmacol , 174 Suppl 1 (Suppl Suppl 1),
S17-S129. https://doi.org/10.1111/bph.13878
Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E.,
Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E.,
Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J.
A., & Collaborators, C. (2019). THE CONCISE GUIDE TO PHARMACOLOGY
2019/20: G protein-coupled receptors. Br J Pharmacol , 176
Suppl 1 (Suppl 1), S21-S141. https://doi.org/10.1111/bph.14748
Alkufri, F., Shaag, A., Abu-Libdeh, B., & Elpeleg, O. (2016).
Deleterious mutation in GPR88 is associated with chorea, speech delay,
and learning disabilities. Neurol Genet , 2 (3), e64.
https://doi.org/10.1212/NXG.0000000000000064
Anton, R. F. (2008). Naltrexone for the management of alcohol
dependence. New England Journal of Medicine , 359 (7),
715-721.
Batalla, A., Homberg, J. R., Lipina, T. V., Sescousse, G., Luijten, M.,
Ivanova, S. A., Schellekens, A. F. A., & Loonen, A. J. M. (2017). The
role of the habenula in the transition from reward to misery in
substance use and mood disorders. Neurosci Biobehav Rev ,80 , 276-285.
https://doi.org/10.1016/j.neubiorev.2017.03.019
Ben Hamida, S., Carter, M., Darcq, E., Sourty, M., Rahman, M. T.,
Decker, A. M., Jin, C., & Kieffer, B. L. (2022). The GPR88 agonist
RTI-13951-33 reduces alcohol drinking and seeking in mice. Addict
Biol , 27 (6), e13227. https://doi.org/10.1111/adb.13227
Ben Hamida, S., Mendonca-Netto, S., Arefin, T. M., Nasseef, M. T.,
Boulos, L. J., McNicholas, M., Ehrlich, A. T., Clarke, E., Moquin, L.,
Gratton, A., Darcq, E., Harsan, L. A., Maldonado, R., & Kieffer, B. L.
(2018). Increased Alcohol Seeking in Mice Lacking Gpr88 Involves
Dysfunctional Mesocorticolimbic Networks. Biol Psychiatry ,84 (3), 202-212.
https://doi.org/10.1016/j.biopsych.2018.01.026
Bianco, I. H., & Wilson, S. W. (2009). The habenular nuclei: a
conserved asymmetric relay station in the vertebrate brain. Philos
Trans R Soc Lond B Biol Sci , 364 (1519), 1005-1020.
https://doi.org/10.1098/rstb.2008.0213
Bjarnadottir, T. K., Fredriksson, R., & Schioth, H. B. (2005). The gene
repertoire and the common evolutionary history of glutamate, pheromone
(V2R), taste(1) and other related G protein-coupled receptors.Gene , 362 , 70-84.
https://doi.org/10.1016/j.gene.2005.07.029
Boden, J. M., & Fergusson, D. M. (2011). Alcohol and depression.Addiction , 106 (5), 906-914.
https://doi.org/10.1111/j.1360-0443.2010.03351.x
Boulos, L. J., Darcq, E., & Kieffer, B. L. (2017). Translating the
Habenula-From Rodents to Humans. Biol Psychiatry , 81 (4),
296-305. https://doi.org/10.1016/j.biopsych.2016.06.003
Brice, N. L., Schiffer, H. H., Monenschein, H., Mulligan, V. J., Page,
K., Powell, J., Xu, X., Cheung, T., Burley, J. R., & Sun, H. (2021).
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist
Effective in Models of Parkinson Disease. Journal of Pharmacology
and Experimental Therapeutics , 377 (3), 407-416.
Casadó, V., & Casadó-Anguera, V. (2023). What are the current trends in
G protein-coupled receptor targeted drug discovery? In (pp. 1-6): Taylor
& Francis.
Chang, J., Song, Z., Wei, S., Zhou, Y., Ju, J., Yao, P., Jiang, Y., Jin,
H., Chi, X., & Li, N. (2023). Expression Mapping and Functional
Analysis of Orphan G-Protein-Coupled Receptor GPR158 in the Adult Mouse
Brain Using a GPR158 Transgenic Mouse. Biomolecules ,13 (3). https://doi.org/10.3390/biom13030479
Dandekar, M. P., Singru, P. S., Kokare, D. M., & Subhedar, N. K.
(2008). Transient up-regulation of cocaine- and amphetamine-regulated
transcript peptide (CART) immunoreactivity following ethanol withdrawal
in rat hypothalamus. Brain Res , 1240 , 119-131.
https://doi.org/10.1016/j.brainres.2008.09.023
Dayas, C. V., McGranahan, T. M., Martin-Fardon, R., & Weiss, F. (2008).
Stimuli linked to ethanol availability activate hypothalamic CART and
orexin neurons in a reinstatement model of relapse. Biol
Psychiatry , 63 (2), 152-157.
https://doi.org/10.1016/j.biopsych.2007.02.002
Dominguez, G. (2006). The CART gene: structure and regulation.Peptides , 27 (8), 1913-1918.
https://doi.org/10.1016/j.peptides.2006.01.025
Douglass, J., & Daoud, S. (1996). Characterization of the human cDNA
and genomic DNA encoding CART: a cocaine- and amphetamine-regulated
transcript. Gene , 169 (2), 241-245.
https://doi.org/10.1016/0378-1119(96)88651-3
Ehrlich, A. T., Maroteaux, G., Robe, A., Venteo, L., Nasseef, M. T., van
Kempen, L. C., Mechawar, N., Turecki, G., Darcq, E., & Kieffer, B. L.
(2018). Expression map of 78 brain-expressed mouse orphan GPCRs provides
a translational resource for neuropsychiatric research.Communications Biology , 1 (1), 102.
Foster, S. R., Hauser, A. S., Vedel, L., Strachan, R. T., Huang, X. P.,
Gavin, A. C., Shah, S. D., Nayak, A. P., Haugaard-Kedstrom, L. M., Penn,
R. B., Roth, B. L., Brauner-Osborne, H., & Gloriam, D. E. (2019).
Discovery of Human Signaling Systems: Pairing Peptides to G
Protein-Coupled Receptors. Cell , 179 (4), 895-908 e821.
https://doi.org/10.1016/j.cell.2019.10.010
Fowler, C. D., & Kenny, P. J. (2012). Habenular signaling in nicotine
reinforcement. Neuropsychopharmacology , 37 (1), 306-307.
https://doi.org/10.1038/npp.2011.197
Fredriksson, R., Lagerstrom, M. C., Lundin, L. G., & Schioth, H. B.
(2003). The G-protein-coupled receptors in the human genome form five
main families. Phylogenetic analysis, paralogon groups, and
fingerprints. Mol Pharmacol , 63 (6), 1256-1272.
https://doi.org/10.1124/mol.63.6.1256
Freitas-Lima, L. C., Pacesova, A., Stanurova, J., Sacha, P., Marek, A.,
Hubalek, M., Kunes, J., Zelezna, B., & Maletinska, L. (2023). GPR160 is
not a receptor of anorexigenic cocaine- and amphetamine-regulated
transcript peptide. Eur J Pharmacol , 949 , 175713.
https://doi.org/10.1016/j.ejphar.2023.175713
Fricker, L. D., & Devi, L. A. (2018). Orphan neuropeptides and
receptors: Novel therapeutic targets. Pharmacol Ther , 185 ,
26-33. https://doi.org/10.1016/j.pharmthera.2017.11.006
Funayama, Y., Li, H., Ishimori, E., Kawatake-Kuno, A., Inaba, H.,
Yamagata, H., Seki, T., Nakagawa, S., Watanabe, Y., Murai, T., Oishi,
N., & Uchida, S. (2023). Antidepressant Response and Stress Resilience
Are Promoted by CART Peptides in GABAergic Neurons of the Anterior
Cingulate Cortex. Biol Psychiatry Glob Open Sci , 3 (1),
87-98. https://doi.org/10.1016/j.bpsgos.2021.12.009
Ghate, A., Befort, K., Becker, J. A., Filliol, D., Bole-Feysot, C.,
Demebele, D., Jost, B., Koch, M., & Kieffer, B. L. (2007).
Identification of novel striatal genes by expression profiling in adult
mouse brain. Neuroscience , 146 (3), 1182-1192.
https://doi.org/10.1016/j.neuroscience.2007.02.040
Gilpin, N. W., Herman, M. A., & Roberto, M. (2015). The central
amygdala as an integrative hub for anxiety and alcohol use disorders.Biol Psychiatry , 77 (10), 859-869.
https://doi.org/10.1016/j.biopsych.2014.09.008
Haddock, C. J., Almeida-Pereira, G., Stein, L. M., Hayes, M. R., Kolar,
G. R., Samson, W. K., & Yosten, G. L. C. (2021). Signaling in rat
brainstem via Gpr160 is required for the anorexigenic and antidipsogenic
actions of cocaine- and amphetamine-regulated transcript peptide.Am J Physiol Regul Integr Comp Physiol , 320 (3), R236-R249.
https://doi.org/10.1152/ajpregu.00096.2020
Hajj, M., De Vita, T., Vol, C., Renassia, C., Bologna, J. C., Brabet,
I., Cazade, M., Pastore, M., Blahos, J., Labesse, G., Pin, J. P., &
Prezeau, L. (2019). Nonclassical Ligand-Independent Regulation of Go
Protein by an Orphan Class C G-Protein-Coupled Receptor. Mol
Pharmacol , 96 (2), 233-246.
https://doi.org/10.1124/mol.118.113019
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schioth, H. B., &
Gloriam, D. E. (2017). Trends in GPCR drug discovery: new agents,
targets and indications. Nat Rev Drug Discov , 16 (12),
829-842. https://doi.org/10.1038/nrd.2017.178
Hauser, A. S., Chavali, S., Masuho, I., Jahn, L. J., Martemyanov, K. A.,
Gloriam, D. E., & Babu, M. M. (2018). Pharmacogenomics of GPCR Drug
Targets. Cell , 172 (1-2), 41-54 e19.
https://doi.org/10.1016/j.cell.2017.11.033
Hauser, A. S., Gloriam, D. E., Brauner-Osborne, H., & Foster, S. R.
(2020). Novel approaches leading towards peptide GPCR de-orphanisation.Br J Pharmacol , 177 (5), 961-968.
https://doi.org/10.1111/bph.14950
Heiber, M., Docherty, J. M., Shah, G., Nguyen, T., Cheng, R., Heng, H.
H., Marchese, A., TSUI, L.-C., SHI, X., & GEORGE, S. R. (1995).
Isolation of three novel human genes encoding G protein-coupled
receptors. DNA and cell biology , 14 (1), 25-35.
Heiman, M., Schaefer, A., Gong, S., Peterson, J. D., Day, M., Ramsey, K.
E., Suarez-Farinas, M., Schwarz, C., Stephan, D. A., & Surmeier, D. J.
(2008). A translational profiling approach for the molecular
characterization of CNS cell types. Cell , 135 (4), 738-748.
Ignatov, A., Lintzel, J., Kreienkamp, H. J., & Schaller, H. C. (2003).
Sphingosine-1-phosphate is a high-affinity ligand for the G
protein-coupled receptor GPR6 from mouse and induces intracellular Ca2+
release by activating the sphingosine-kinase pathway. Biochem
Biophys Res Commun , 311 (2), 329-336.
https://doi.org/10.1016/j.bbrc.2003.10.006
Jaworski, J. N., Hansen, S. T., Kuhar, M. J., & Mark, G. P. (2008).
Injection of CART (cocaine- and amphetamine-regulated transcript)
peptide into the nucleus accumbens reduces cocaine self-administration
in rats. Behav Brain Res , 191 (2), 266-271.
https://doi.org/10.1016/j.bbr.2008.03.039
Jeong, E., Kim, Y., Jeong, J., & Cho, Y. (2021). Structure of the class
C orphan GPCR GPR158 in complex with RGS7-Gbeta5. Nat Commun ,12 (1), 6805. https://doi.org/10.1038/s41467-021-27147-1
Jin, C., Decker, A. M., Makhijani, V. H., Besheer, J., Darcq, E.,
Kieffer, B. L., & Maitra, R. (2018). Discovery of a Potent, Selective,
and Brain-Penetrant Small Molecule that Activates the Orphan Receptor
GPR88 and Reduces Alcohol Intake. J Med Chem , 61 (15),
6748-6758. https://doi.org/10.1021/acs.jmedchem.8b00566
Jones, P. G., Nawoschik, S. P., Sreekumar, K., Uveges, A. J., Tseng, E.,
Zhang, L., Johnson, J., He, L., Paulsen, J. E., & Bates, B. (2007).
Tissue distribution and functional analyses of the constitutively active
orphan G protein coupled receptors, GPR26 and GPR78. Biochimica et
Biophysica Acta (BBA)-General Subjects , 1770 (6), 890-901.
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011). The efficacy of
disulfiram for the treatment of alcohol use disorder. Alcoholism:
Clinical and Experimental Research , 35 (10), 1749-1758.
Jung, S. K., Hong, M.-S., Suh, G.-J., Jin, S.-Y., Lee, H. J., Kim, B.
S., Lim, Y. J., Kim, M. K., Park, H.-K., & Chung, J.-H. (2004).
Association between polymorphism in intron 1 of cocaine-and
amphetamine-regulated transcript gene with alcoholism, but not with
bipolar disorder and schizophrenia in Korean population.Neuroscience letters , 365 (1), 54-57.
Kalivas, P. W., & Volkow, N. D. (2005). The neural basis of addiction:
a pathology of motivation and choice. Am J Psychiatry ,162 (8), 1403-1413.
https://doi.org/10.1176/appi.ajp.162.8.1403
Khrimian, L., Obri, A., Ramos-Brossier, M., Rousseaud, A., Moriceau, S.,
Nicot, A. S., Mera, P., Kosmidis, S., Karnavas, T., Saudou, F., Gao, X.
B., Oury, F., Kandel, E., & Karsenty, G. (2017). Gpr158 mediates
osteocalcin’s regulation of cognition. J Exp Med , 214 (10),
2859-2873. https://doi.org/10.1084/jem.20171320
King, B. J., Furlong, T. M., & McNally, G. P. (2010). Cocaine and
amphetamine related transcript (CART) inhibits context induced
reinstatement of reward seeking. Behav Neurosci , 124 (3),
423-427. https://doi.org/10.1037/a0019540
Kolb, P., Kenakin, T., Alexander, S. P. H., Bermudez, M., Bohn, L. M.,
Breinholt, C. S., Bouvier, M., Hill, S. J., Kostenis, E., Martemyanov,
K. A., Neubig, R. R., Onaran, H. O., Rajagopal, S., Roth, B. L., Selent,
J., Shukla, A. K., Sommer, M. E., & Gloriam, D. E. (2022). Community
guidelines for GPCR ligand bias: IUPHAR review 32. Br J
Pharmacol , 179 (14), 3651-3674.
https://doi.org/10.1111/bph.15811
Kononoff, J., Kallupi, M., Kimbrough, A., Conlisk, D., de Guglielmo, G.,
& George, O. (2018). Systemic and Intra-Habenular Activation of the
Orphan G Protein-Coupled Receptor GPR139 Decreases Compulsive-Like
Alcohol Drinking and Hyperalgesia in Alcohol-Dependent Rats.eNeuro , 5 (3).
https://doi.org/10.1523/ENEURO.0153-18.2018
Koylu, E. O., Couceyro, P. R., Lambert, P. D., & Kuhar, M. J. (1998).
Cocaine- and amphetamine-regulated transcript peptide
immunohistochemical localization in the rat brain. J Comp Neurol ,391 (1), 115-132.
https://www.ncbi.nlm.nih.gov/pubmed/9527537
Kranzler, H. R., & Soyka, M. (2018). Diagnosis and pharmacotherapy of
alcohol use disorder: a review. Jama , 320 (8), 815-824.
Kreitzer, A. C., & Malenka, R. C. (2008). Striatal plasticity and basal
ganglia circuit function. Neuron , 60 (4), 543-554.
Kuhar, M. J. (2016). CART Peptides and Drugs of Abuse: A Review of
Recent Progress. J Drug Alcohol Res , 5 .
https://doi.org/10.4303/jdar/235984
Kuhar, M. J., Adams, S., Dominguez, G., Jaworski, J., & Balkan, B.
(2002). CART peptides. Neuropeptides , 36 (1), 1-8.
https://doi.org/10.1054/npep.2002.0887
Laboute, T., Zucca, S., Holcomb, M., Patil, D. N., Garza, C., Wheatley,
B. A., Roy, R. N., Forli, S., & Martemyanov, K. A. (2023). Orphan
receptor GPR158 serves as a metabotropic glycine receptor: mGlyR.Science , 379 (6639), 1352-1358.
https://doi.org/10.1126/science.add7150
Lakatos, A., Prinster, S., Vicentic, A., Hall, R. A., & Kuhar, M. J.
(2005). Cocaine- and amphetamine-regulated transcript (CART) peptide
activates the extracellular signal-regulated kinase (ERK) pathway in
AtT20 cells via putative G-protein coupled receptors. Neurosci
Lett , 384 (1-2), 198-202.
https://doi.org/10.1016/j.neulet.2005.04.072
Lau, J., & Herzog, H. (2014). CART in the regulation of appetite and
energy homeostasis. Front Neurosci , 8 , 313.
https://doi.org/10.3389/fnins.2014.00313
Laun, A. S., Shrader, S. H., Brown, K. J., & Song, Z.-H. (2019). GPR3,
GPR6, and GPR12 as novel molecular targets: their biological functions
and interaction with cannabidiol. Acta Pharmacologica Sinica ,40 (3), 300-308.
Laun, A. S., & Song, Z.-H. (2017). GPR3 and GPR6, novel molecular
targets for cannabidiol. Biochemical and biophysical research
communications , 490 (1), 17-21.
Lee, D. K., George, S. R., O’Dowd, B. F., Evans, J. F., & Lynch, K. R.
(2001). Orphan G protein-coupled receptors in the CNS. Current
opinion in pharmacology , 1 (1), 31-39.
Li, J. X., Thorn, D. A., & Jin, C. (2013). The GPR88 receptor agonist
2-PCCA does not alter the behavioral effects of methamphetamine in rats.Eur J Pharmacol , 698 (1-3), 272-277.
https://doi.org/10.1016/j.ejphar.2012.10.037
Lin, Y., Hall, R. A., & Kuhar, M. J. (2011). CART peptide stimulation
of G protein-mediated signaling in differentiated PC12 cells:
identification of PACAP 6-38 as a CART receptor antagonist.Neuropeptides , 45 (5), 351-358.
https://doi.org/10.1016/j.npep.2011.07.006
Liu, C., Bonaventure, P., Lee, G., Nepomuceno, D., Kuei, C., Wu, J., Li,
Q., Joseph, V., Sutton, S. W., Eckert, W., Yao, X., Yieh, L., Dvorak,
C., Carruthers, N., Coate, H., Yun, S., Dugovic, C., Harrington, A., &
Lovenberg, T. W. (2015). GPR139, an Orphan Receptor Highly Enriched in
the Habenula and Septum, Is Activated by the Essential Amino Acids
L-Tryptophan and L-Phenylalanine. Mol Pharmacol , 88 (5),
911-925. https://doi.org/10.1124/mol.115.100412
Lobo, M. K., Cui, Y., Ostlund, S. B., Balleine, B. W., & William Yang,
X. (2007). Genetic control of instrumental conditioning by
striatopallidal neuron–specific S1P receptor Gpr6. Nature
neuroscience , 10 (11), 1395-1397.
Logue, S. F., Grauer, S. M., Paulsen, J., Graf, R., Taylor, N., Sung, M.
A., Zhang, L., Hughes, Z., Pulito, V. L., Liu, F., Rosenzweig-Lipson,
S., Brandon, N. J., Marquis, K. L., Bates, B., & Pausch, M. (2009). The
orphan GPCR, GPR88, modulates function of the striatal dopamine system:
a possible therapeutic target for psychiatric disorders? Mol Cell
Neurosci , 42 (4), 438-447.
https://doi.org/10.1016/j.mcn.2009.09.007
Maddern, X. J., Letherby, B., Ch’ng, S. S., Pearl, A., Gogos, A.,
Lawrence, A. J., & Walker, L. C. (2023). Cocaine and amphetamine
regulated transcript (CART) mediates sex differences in binge drinking
through central taste circuits. Neuropsychopharmacology .
https://doi.org/10.1038/s41386-023-01712-2
Marchese, A., Cheng, R., Lee, M. C., Porter, C. A., Heiber, M., Goodman,
M., George, S. R., & O’Dowd, B. F. (1994). Mapping studies of two G
protein-coupled receptor genes: an amino acid difference may confer a
functional variation between a human and rodent receptor. Biochem
Biophys Res Commun , 205 (3), 1952-1958.
https://doi.org/10.1006/bbrc.1994.2899
Margolin, D. H., Brice, N. L., Davidson, A. M., Matthews, K. L., &
Carlton, M. B. (2022). A Phase I, First-in-Human, Healthy Volunteer
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of
CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for
Parkinson’s Disease. Journal of Pharmacology and Experimental
Therapeutics , 381 (1), 33-41.
Maroteaux, G., Arefin, T. M., Harsan, L. A., Darcq, E., Ben Hamida, S.,
& Kieffer, B. L. (2018). Lack of anticipatory behavior in Gpr88
knockout mice showed by automatized home cage phenotyping. Genes
Brain Behav , 17 (8), e12473.
https://doi.org/10.1111/gbb.12473
Massart, R., Guilloux, J. P., Mignon, V., Sokoloff, P., & Diaz, J.
(2009). Striatal GPR88 expression is confined to the whole projection
neuron population and is regulated by dopaminergic and glutamatergic
afferents. Eur J Neurosci , 30 (3), 397-414.
https://doi.org/10.1111/j.1460-9568.2009.06842.x
Matsuo, A., Matsumoto, S., Nagano, M., Masumoto, K. H., Takasaki, J.,
Matsumoto, M., Kobori, M., Katoh, M., & Shigeyoshi, Y. (2005).
Molecular cloning and characterization of a novel Gq-coupled orphan
receptor GPRg1 exclusively expressed in the central nervous system.Biochem Biophys Res Commun , 331 (1), 363-369.
https://doi.org/10.1016/j.bbrc.2005.03.174
McLaughlin, I., Dani, J. A., & De Biasi, M. (2017). The medial habenula
and interpeduncular nucleus circuitry is critical in addiction, anxiety,
and mood regulation. J Neurochem , 142 Suppl 2 (Suppl 2),
130-143. https://doi.org/10.1111/jnc.14008
Meirsman, A. C., Ben Hamida, S., Clarke, E., de Kerchove d’Exaerde, A.,
Darcq, E., & Kieffer, B. L. (2019). GPR88 in D1R-Type and D2R-Type
Medium Spiny Neurons Differentially Regulates Affective and Motor
Behavior. eNeuro , 6 (4).
https://doi.org/10.1523/ENEURO.0035-19.2019
Meirsman, A. C., Le Merrer, J., Pellissier, L. P., Diaz, J., Clesse, D.,
Kieffer, B. L., & Becker, J. A. (2016). Mice Lacking GPR88 Show Motor
Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta
Opioid Antagonist. Biol Psychiatry , 79 (11), 917-927.
https://doi.org/10.1016/j.biopsych.2015.05.020
Meirsman, A. C., Robe, A., de Kerchove d’Exaerde, A., & Kieffer, B. L.
(2016). GPR88 in A2AR Neurons Enhances Anxiety-Like Behaviors.eNeuro , 3 (4).
https://doi.org/10.1523/ENEURO.0202-16.2016
Millan, E. Z., & McNally, G. P. (2012). Cocaine- and
amphetamine-regulated transcript in the nucleus accumbens shell
attenuates context-induced reinstatement of alcohol seeking. Behav
Neurosci , 126 (5), 690-698.
https://doi.org/10.1037/a0029953
Mizushima, K., Miyamoto, Y., Tsukahara, F., Hirai, M., Sakaki, Y., &
Ito, T. (2000). A novel G-protein-coupled receptor gene expressed in
striatum. Genomics , 69 (3), 314-321.
https://doi.org/10.1006/geno.2000.6340
Mogi, C., Tomura, H., Tobo, M., Wang, J. Q., Damirin, A., Kon, J.,
Komachi, M., Hashimoto, K., Sato, K., & Okajima, F. (2005).
Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer
G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate
production and cAMP accumulation. J Pharmacol Sci , 99 (2),
160-167. https://doi.org/10.1254/jphs.fp0050599
Munster, A., Sommer, S., Kukelova, D., Sigrist, H., Koros, E., Deiana,
S., Klinder, K., Baader-Pagler, T., Mayer-Wrangowski, S., Ferger, B.,
Bretschneider, T., Pryce, C. R., Hauber, W., & von Heimendahl, M.
(2022). Effects of GPR139 agonism on effort expenditure for food reward
in rodent models: Evidence for pro-motivational actions.Neuropharmacology , 213 , 109078.
https://doi.org/10.1016/j.neuropharm.2022.109078
Navandar, M., Martín-García, E., Maldonado, R., Lutz, B., Gerber, S., &
Ruiz de Azua, I. (2021). Transcriptional signatures in prefrontal cortex
confer vulnerability versus resilience to food and cocaine
addiction-like behavior. Scientific Reports , 11 (1), 9076.
Nohr, A. C., Shehata, M. A., Hauser, A. S., Isberg, V., Mokrosinski, J.,
Andersen, K. B., Farooqi, I. S., Pedersen, D. S., Gloriam, D. E., &
Brauner-Osborne, H. (2017). The orphan G protein-coupled receptor GPR139
is activated by the peptides: Adrenocorticotropic hormone (ACTH),
alpha-, and beta-melanocyte stimulating hormone (alpha-MSH, and
beta-MSH), and the conserved core motif HFRW. Neurochem Int ,102 , 105-113. https://doi.org/10.1016/j.neuint.2016.11.012
Nona, C. N., Hendershot, C. S., & Le Foll, B. (2019). Effects of
cannabidiol on alcohol-related outcomes: A review of preclinical and
human research. Experimental and Clinical Psychopharmacology ,27 (4), 359.
Oeckl, P., Hengerer, B., & Ferger, B. (2014). G-protein coupled
receptor 6 deficiency alters striatal dopamine and cAMP concentrations
and reduces dyskinesia in a mouse model of Parkinson’s disease.Experimental neurology , 257 , 1-9.
Ong, Z. Y., & McNally, G. P. (2020). CART in energy balance and drug
addiction: Current insights and mechanisms. Brain Res ,1740 , 146852.
https://doi.org/10.1016/j.brainres.2020.146852
Orlandi, C., Xie, K., Masuho, I., Fajardo-Serrano, A., Lujan, R., &
Martemyanov, K. A. (2015). Orphan Receptor GPR158 Is an Allosteric
Modulator of RGS7 Catalytic Activity with an Essential Role in Dictating
Its Expression and Localization in the Brain. J Biol Chem ,290 (22), 13622-13639.
https://doi.org/10.1074/jbc.M115.645374
Pandey, S. C., Chartoff, E. H., Carlezon, W. A., Jr., Zou, J., Zhang,
H., Kreibich, A. S., Blendy, J. A., & Crews, F. T. (2005). CREB gene
transcription factors: role in molecular mechanisms of alcohol and drug
addiction. Alcohol Clin Exp Res , 29 (2), 176-184.
https://doi.org/10.1097/01.alc.0000153550.31168.1d
Patil, D. N., Singh, S., Laboute, T., Strutzenberg, T. S., Qiu, X., Wu,
D., Novick, S. J., Robinson, C. V., Griffin, P. R., Hunt, J. F., Izard,
T., Singh, A. K., & Martemyanov, K. A. (2022). Cryo-EM structure of
human GPR158 receptor coupled to the RGS7-Gbeta5 signaling complex.Science , 375 (6576), 86-91.
https://doi.org/10.1126/science.abl4732
Prud’homme, M., Cata, R., & Jutras-Aswad, D. (2015). Cannabidiol as an
intervention for addictive behaviors: a systematic review of the
evidence. Substance abuse: research and treatment , 9 ,
SART. S25081.
Quintana, A., Sanz, E., Wang, W., Storey, G. P., Guler, A. D., Wanat, M.
J., Roller, B. A., La Torre, A., Amieux, P. S., McKnight, G. S.,
Bamford, N. S., & Palmiter, R. D. (2012). Lack of GPR88 enhances medium
spiny neuron activity and alters motor- and cue-dependent behaviors.Nat Neurosci , 15 (11), 1547-1555.
https://doi.org/10.1038/nn.3239
Rabiner, E. A., Uz, T., Mansur, A., Brown, T., Chen, G., Wu, J.,
Atienza, J., Schwarz, A. J., Yin, W., Lewis, Y., Searle, G. E.,
Dennison, J., Passchier, J., Gunn, R. N., & Tauscher, J. (2022).
Endogenous dopamine release in the human brain as a pharmacodynamic
biomarker: evaluation of the new GPR139 agonist TAK-041 with
[(11)C]PHNO PET. Neuropsychopharmacology , 47 (7),
1405-1412. https://doi.org/10.1038/s41386-021-01204-1
Reichard, H. A., Schiffer, H. H., Monenschein, H., Atienza, J. M.,
Corbett, G., Skaggs, A. W., Collia, D. R., Ray, W. J., Serrats, J.,
Bliesath, J., Kaushal, N., Lam, B. P., Amador-Arjona, A., Rahbaek, L.,
McConn, D. J., Mulligan, V. J., Brice, N., Gaskin, P. L. R., Cilia, J.,
& Hitchcock, S. (2021). Discovery of TAK-041: a Potent and Selective
GPR139 Agonist Explored for the Treatment of Negative Symptoms
Associated with Schizophrenia. J Med Chem , 64 (15),
11527-11542. https://doi.org/10.1021/acs.jmedchem.1c00820
Rodriguez, F. D., Sanchez, M. L., & Covenas, R. (2023). Neurotensin and
Alcohol Use Disorders: Towards a Pharmacological Treatment. Int J
Mol Sci , 24 (10). https://doi.org/10.3390/ijms24108656
Roth, B. L., & Kroeze, W. K. (2015). Integrated Approaches for
Genome-wide Interrogation of the Druggable Non-olfactory G
Protein-coupled Receptor Superfamily. J Biol Chem ,290 (32), 19471-19477.
https://doi.org/10.1074/jbc.R115.654764
Salinas, A. G., Nguyen, C. T., Ahmadi-Tehrani, D., & Morrisett, R. A.
(2014). Reduced ethanol consumption and preference in cocaine- and
amphetamine-regulated transcript (CART) knockout mice. Addict
Biol , 19 (2), 175-184.
https://doi.org/10.1111/j.1369-1600.2012.00475.x
Schank, J. R. (2020). Neurokinin receptors in drug and alcohol
addiction. Brain Res , 1734 , 146729.
https://doi.org/10.1016/j.brainres.2020.146729
Shoblock, J. R., Welty, N., Fraser, I., Wyatt, R., Lord, B., Lovenberg,
T., Liu, C., & Bonaventure, P. (2019). In vivo Characterization of a
Selective, Orally Available, and Brain Penetrant Small Molecule GPR139
Agonist. Front Pharmacol , 10 , 273.
https://doi.org/10.3389/fphar.2019.00273
Shrader, S. H., & Song, Z.-H. (2020). Discovery of endogenous inverse
agonists for G protein-coupled receptor 6. Biochemical and
biophysical research communications , 522 (4), 1041-1045.
Sinha, R. (2012). How does stress lead to risk of alcohol relapse?Alcohol Res , 34 (4), 432-440.
https://www.ncbi.nlm.nih.gov/pubmed/23584109
Somalwar, A. R., Choudhary, A. G., Sharma, P. R., B, N., Sagarkar, S.,
Sakharkar, A. J., Subhedar, N. K., & Kokare, D. M. (2018). Cocaine- and
amphetamine-regulated transcript peptide (CART) induced reward behavior
is mediated via G(i/o) dependent phosphorylation of PKA/ERK/CREB
pathway. Behav Brain Res , 348 , 9-21.
https://doi.org/10.1016/j.bbr.2018.03.035
Song, C., Orlandi, C., Sutton, L. P., & Martemyanov, K. A. (2019). The
signaling proteins GPR158 and RGS7 modulate excitability of L2/3
pyramidal neurons and control A-type potassium channel in the prelimbic
cortex. J Biol Chem , 294 (35), 13145-13157.
https://doi.org/10.1074/jbc.RA119.007533
Song, Z., Young III, W. S., Brownstein, M. J., & Bonner, T. I. (1994).
Molecular cloning of a novel candidate G protein-coupled receptor from
rat brain. FEBS letters , 351 (3), 375-379.
Spanagel, R., Vengeliene, V., Jandeleit, B., Fischer, W. N., Grindstaff,
K., Zhang, X., Gallop, M. A., Krstew, E. V., Lawrence, A. J., & Kiefer,
F. (2014). Acamprosate produces its anti-relapse effects via calcium.Neuropsychopharmacology , 39 (4), 783-791.
https://doi.org/10.1038/npp.2013.264
Spiess, J., Villarreal, J., & Vale, W. (1981). Isolation and sequence
analysis of a somatostatin-like polypeptide from ovine hypothalamus.Biochemistry , 20 (7), 1982-1988.
https://doi.org/10.1021/bi00510a038
Stoveken, H. M., Zucca, S., Masuho, I., Grill, B., & Martemyanov, K. A.
(2020). The orphan receptor GPR139 signals via G(q/11) to oppose opioid
effects. J Biol Chem , 295 (31), 10822-10830.
https://doi.org/10.1074/jbc.AC120.014770
Susens, U., Hermans-Borgmeyer, I., Urny, J., & Schaller, H. C. (2006).
Characterisation and differential expression of two very closely related
G-protein-coupled receptors, GPR139 and GPR142, in mouse tissue and
during mouse development. Neuropharmacology , 50 (4),
512-520. https://doi.org/10.1016/j.neuropharm.2005.11.003
Sutton, L. P., Orlandi, C., Song, C., Oh, W. C., Muntean, B. S., Xie,
K., Filippini, A., Xie, X., Satterfield, R., Yaeger, J. D. W., Renner,
K. J., Young, S. M., Jr., Xu, B., Kwon, H., & Martemyanov, K. A.
(2018). Orphan receptor GPR158 controls stress-induced depression.Elife , 7 . https://doi.org/10.7554/eLife.33273
Takeda, S., Kadowaki, S., Haga, T., Takaesu, H., & Mitaku, S. (2002).
Identification of G protein-coupled receptor genes from the human genome
sequence. FEBS Lett , 520 (1-3), 97-101.
https://doi.org/10.1016/s0014-5793(02)02775-8
Tanaka, S., Ishii, K., Kasai, K., Yoon, S. O., & Saeki, Y. (2007).
Neural expression of G protein-coupled receptors GPR3, GPR6, and GPR12
up-regulates cyclic AMP levels and promotes neurite outgrowth.Journal of Biological Chemistry , 282 (14), 10506-10515.
Tao, Y. X., & Conn, P. M. (2014). Chaperoning G Protein-Coupled
Receptors: From Cell Biology to Therapeutics. Endocrine Reviews ,35 (4), 602-647. https://doi.org/10.1210/er.2013-1121
Uhlenbrock, K., Gassenhuber, H., & Kostenis, E. (2002). Sphingosine
1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of
constitutively active G protein-coupled receptors. Cellular
signalling , 14 (11), 941-953.
Van Waes, V., Tseng, K. Y., & Steiner, H. (2011). GPR88 - a putative
signaling molecule predominantly expressed in the striatum: Cellular
localization and developmental regulation. Basal Ganglia ,1 (2), 83-89. https://doi.org/10.1016/j.baga.2011.04.001
Vicentic, A., & Jones, D. C. (2007). The CART (cocaine- and
amphetamine-regulated transcript) system in appetite and drug addiction.J Pharmacol Exp Ther , 320 (2), 499-506.
https://doi.org/10.1124/jpet.105.091512
Walker, L. C. (2021). A balancing act: the role of pro- and anti-stress
peptides within the central amygdala in anxiety and alcohol use
disorders. J Neurochem , 157 (5), 1615-1643.
https://doi.org/10.1111/jnc.15301
Walker, L. C., Berizzi, A. E., Chen, N. A., Rueda, P., Perreau, V. M.,
Huckstep, K., Srisontiyakul, J., Govitrapong, P., Xiaojian, J.,
Lindsley, C. W., Jones, C. K., Riddy, D. M., Christopoulos, A.,
Langmead, C. J., & Lawrence, A. J. (2020). Acetylcholine Muscarinic
M(4) Receptors as a Therapeutic Target for Alcohol Use Disorder:
Converging Evidence From Humans and Rodents. Biol Psychiatry ,88 (12), 898-909.
https://doi.org/10.1016/j.biopsych.2020.02.019
Walker, L. C., Hand, L. J., Letherby, B., Huckstep, K. L., Campbell, E.
J., & Lawrence, A. J. (2021). Cocaine and amphetamine regulated
transcript (CART) signalling in the central nucleus of the amygdala
modulates stress-induced alcohol seeking.Neuropsychopharmacology , 46 (2), 325-333.
https://doi.org/10.1038/s41386-020-00807-4
Walker, L. C., Huckstep, K. L., Becker, H. C., Langmead, C. J., &
Lawrence, A. J. (2023). Targeting muscarinic receptors for the treatment
of alcohol use disorders: Opportunities and hurdles for clinical
development. Br J Pharmacol .
https://doi.org/10.1111/bph.16081
Walker, L. C., & Lawrence, A. J. (2018). Investigational drug therapies
in phase I and phase II clinical trials for alcohol use disorders.Expert Opin Investig Drugs , 1-14.
https://doi.org/10.1080/13543784.2018.1502269
Wang, J., Zhu, L. Y., Liu, Q., Hentzer, M., Smith, G. P., & Wang, M. W.
(2015). High-throughput screening of antagonists for the orphan
G-protein coupled receptor GPR139. Acta Pharmacol Sin ,36 (7), 874-878. https://doi.org/10.1038/aps.2015.12
Wang, L., Lee, G., Kuei, C., Yao, X., Harrington, A., Bonaventure, P.,
Lovenberg, T. W., & Liu, C. (2019). GPR139 and Dopamine D2 Receptor
Co-express in the Same Cells of the Brain and May Functionally Interact.Front Neurosci , 13 , 281.
https://doi.org/10.3389/fnins.2019.00281
Wang, L., Lee, G., Shih, A., Kuei, C., Nepomuceno, D., Wennerholm, M.,
Fan, F., Wu, J., Bonaventure, P., Lovenberg, T. W., & Liu, C. (2019).
Mutagenesis of GPR139 reveals ways to create gain or loss of function
receptors. Pharmacol Res Perspect , 7 (1), e00466.
https://doi.org/10.1002/prp2.466
Wang, T., Zhou, G., He, M., Xu, Y., Rusyniak, W. G., Xu, Y., Ji, Y.,
Simon, R. P., Xiong, Z. G., & Zha, X. M. (2020). GPR68 Is a
Neuroprotective Proton Receptor in Brain Ischemia. Stroke ,51 (12), 3690-3700.
https://doi.org/10.1161/STROKEAHA.120.031479
Wei, S., Zheng, L., Chang, J., Jiang, J., Zhou, Z., Liao, H., Song, K.,
Liu, X., Chi, X., Li, H., Kuang, X., & Li, N. (2023). G protein-coupled
receptor 158 modulates sensitivity to the sedative-hypnotic effect of
ethanol in male mice. Alcohol Clin Exp Res (Hoboken) ,47 (7), 1261-1270. https://doi.org/10.1111/acer.15094
Witkiewitz, K., Saville, K., & Hamreus, K. (2012). Acamprosate for
treatment of alcohol dependence: mechanisms, efficacy, and clinical
utility. Ther Clin Risk Manag , 8 , 45-53.
https://doi.org/10.2147/TCRM.S23184
Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F., Nguyen, D.
G., Caldwell, J. S., & Chen, Y. A. (2009). Lipid G protein-coupled
receptor ligand identification using beta-arrestin PathHunter assay.J Biol Chem , 284 (18), 12328-12338.
https://doi.org/10.1074/jbc.M806516200
Yin, W., Han, D., Khudyakov, P., Behrje, R., Posener, J., Laurenza, A.,
& Arkilo, D. (2022). A phase 1 study to evaluate the safety,
tolerability and pharmacokinetics of TAK-041 in healthy participants and
patients with stable schizophrenia. Br J Clin Pharmacol ,88 (8), 3872-3882. https://doi.org/10.1111/bcp.15305
Yosten, G. L., Harada, C. M., Haddock, C., Giancotti, L. A., Kolar, G.
R., Patel, R., Guo, C., Chen, Z., Zhang, J., Doyle, T. M., Dickenson, A.
H., Samson, W. K., & Salvemini, D. (2020). GPR160 de-orphanization
reveals critical roles in neuropathic pain in rodents. J Clin
Invest , 130 (5), 2587-2592.
https://doi.org/10.1172/JCI133270
Zhang, L.-L., Wang, J.-J., Liu, Y., Lu, X.-B., Kuang, Y., Wan, Y.-H.,
Chen, Y., Yan, H.-M., Fei, J., & Wang, Z.-G. (2011). GPR26-deficient
mice display increased anxiety-and depression-like behaviors accompanied
by reduced phosphorylated cyclic AMP responsive element-binding protein
level in central amygdala. Neuroscience , 196 , 203-214.